Millions in Europe Suffer from Untreated Neuropathic Pain Despite New Therapies

Neuropathic pain affects millions across Europe, yet many patients still rely on ineffective treatments. Between 7 and 9 percent of the continent's population lives with this condition, which stems from nerve damage and often leads to severe psychological strain. Despite its prevalence, access to proper care remains uneven, even in countries like Austria where new specialised centres have recently opened.

Neuropathic pain differs from ordinary pain in both cause and sensation. It arises when nerves are damaged or malfunctioning, leading to symptoms like persistent burning, tingling, or extreme sensitivity to touch. Unlike typical pain, it is notoriously difficult to treat and frequently becomes chronic.

Many patients continue using over-the-counter drugs like NSAIDs or paracetamol, though these are often ineffective and carry risks of side effects. Instead, targeted medications, combination therapies, and newer methods such as auricular vagus nerve stimulation (aVNS) are recommended. Experts stress that a multimodal, interdisciplinary approach is essential for managing the condition effectively.

Austria has taken steps to improve care by opening two of three planned interdisciplinary pain centres funded by public health insurance. However, most federal states still lack structured treatment options. While institutions like the PMU in Salzburg conduct research on chronic pain, no dedicated neuropathic pain centres or specialists have been identified in the country.

The consequences of untreated neuropathic pain extend beyond physical discomfort. Chronic suffering frequently triggers depression and heightens suicidal thoughts, making timely and appropriate care critical.

With up to 34 percent of diabetes patients experiencing neuropathic pain, the need for better treatment options is clear. Austria's new pain centres mark progress, but gaps in specialised care persist. Effective management requires not only advanced therapies but also broader access to coordinated, interdisciplinary support.